4//SEC Filing
Donley Matthew Maxwell 4
Accession 0001628280-23-006532
CIK 0001600620other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:29 PM ET
Size
5.4 KB
Accession
0001628280-23-006532
Insider Transaction Report
Form 4
Donley Matthew Maxwell
Chief Operating Officer
Transactions
- Award
Common Stock
2023-03-02+271,134→ 403,141 total
Footnotes (3)
- [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes the 271,134 newly awarded RSUs, 104,080 RSUs previously reported in Table II, which vests in three (3) equal annual installments beginning March 2, 2022 (Prior RSUs), and 27,927 shares of common stock. On March 2, 2023, 34,693 of Prior RSUs vested and 69,387 of Prior RSUs remained unvested.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001636642
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:29 PM ET
- Size
- 5.4 KB